Cargando…
Drug shortage crisis in Sudan in times of COVID-19
Sudan is witnessing severe drugs, medicines, and medical supplies shortages, which present a major impediment to the provision of emergency healthcare services. Drug insecurity in Sudan is as a result of several accumulated factors, primarily due to worsening economic condition, inappropriate pricin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461216/ https://www.ncbi.nlm.nih.gov/pubmed/36101692 http://dx.doi.org/10.1016/j.puhip.2020.100060 |
_version_ | 1784786927925329920 |
---|---|
author | Lucero-Prisno, Don Eliseo Elhadi, Yasir Ahmed Mohammed Modber, Mohamed AbdulKareem Adam Musa, Mohamed Babiker Mohammed, Salma Elmukashfi Eltahir Hassan, Khlood Fathi Dafallah, Alaa Lin, Xu Ahmadi, Attaullah Adeyemi, Sylvester Ekpenyong, Aniekan Adebisi, Yusuff Adebayo |
author_facet | Lucero-Prisno, Don Eliseo Elhadi, Yasir Ahmed Mohammed Modber, Mohamed AbdulKareem Adam Musa, Mohamed Babiker Mohammed, Salma Elmukashfi Eltahir Hassan, Khlood Fathi Dafallah, Alaa Lin, Xu Ahmadi, Attaullah Adeyemi, Sylvester Ekpenyong, Aniekan Adebisi, Yusuff Adebayo |
author_sort | Lucero-Prisno, Don Eliseo |
collection | PubMed |
description | Sudan is witnessing severe drugs, medicines, and medical supplies shortages, which present a major impediment to the provision of emergency healthcare services. Drug insecurity in Sudan is as a result of several accumulated factors, primarily due to worsening economic condition, inappropriate pricing policy, privatization of the pharmaceutical sector, poor manufacturing and weak weak weregulatory system. These could threaten patient health through replacement of highly efficacious medicines with less effective alternatives and by impacting the scheduling of urgent medical operations and procedures. Drug and medicine shortages are of catastrophic impact especially amid the current epidemic of COVID-19 where these are salient needs. Efforts should be quickly directed to ensure immediate access to pharmaceutical products and other essential health commodities. Effective policies on drug importation, production, pricing, and distribution should be established to avoid the consequences of an impending crisis. |
format | Online Article Text |
id | pubmed-9461216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94612162022-09-12 Drug shortage crisis in Sudan in times of COVID-19 Lucero-Prisno, Don Eliseo Elhadi, Yasir Ahmed Mohammed Modber, Mohamed AbdulKareem Adam Musa, Mohamed Babiker Mohammed, Salma Elmukashfi Eltahir Hassan, Khlood Fathi Dafallah, Alaa Lin, Xu Ahmadi, Attaullah Adeyemi, Sylvester Ekpenyong, Aniekan Adebisi, Yusuff Adebayo Public Health Pract (Oxf) Commentary Sudan is witnessing severe drugs, medicines, and medical supplies shortages, which present a major impediment to the provision of emergency healthcare services. Drug insecurity in Sudan is as a result of several accumulated factors, primarily due to worsening economic condition, inappropriate pricing policy, privatization of the pharmaceutical sector, poor manufacturing and weak weak weregulatory system. These could threaten patient health through replacement of highly efficacious medicines with less effective alternatives and by impacting the scheduling of urgent medical operations and procedures. Drug and medicine shortages are of catastrophic impact especially amid the current epidemic of COVID-19 where these are salient needs. Efforts should be quickly directed to ensure immediate access to pharmaceutical products and other essential health commodities. Effective policies on drug importation, production, pricing, and distribution should be established to avoid the consequences of an impending crisis. Elsevier 2020-11-23 /pmc/articles/PMC9461216/ /pubmed/36101692 http://dx.doi.org/10.1016/j.puhip.2020.100060 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Lucero-Prisno, Don Eliseo Elhadi, Yasir Ahmed Mohammed Modber, Mohamed AbdulKareem Adam Musa, Mohamed Babiker Mohammed, Salma Elmukashfi Eltahir Hassan, Khlood Fathi Dafallah, Alaa Lin, Xu Ahmadi, Attaullah Adeyemi, Sylvester Ekpenyong, Aniekan Adebisi, Yusuff Adebayo Drug shortage crisis in Sudan in times of COVID-19 |
title | Drug shortage crisis in Sudan in times of COVID-19 |
title_full | Drug shortage crisis in Sudan in times of COVID-19 |
title_fullStr | Drug shortage crisis in Sudan in times of COVID-19 |
title_full_unstemmed | Drug shortage crisis in Sudan in times of COVID-19 |
title_short | Drug shortage crisis in Sudan in times of COVID-19 |
title_sort | drug shortage crisis in sudan in times of covid-19 |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461216/ https://www.ncbi.nlm.nih.gov/pubmed/36101692 http://dx.doi.org/10.1016/j.puhip.2020.100060 |
work_keys_str_mv | AT luceroprisnodoneliseo drugshortagecrisisinsudanintimesofcovid19 AT elhadiyasirahmedmohammed drugshortagecrisisinsudanintimesofcovid19 AT modbermohamedabdulkareemadam drugshortagecrisisinsudanintimesofcovid19 AT musamohamedbabiker drugshortagecrisisinsudanintimesofcovid19 AT mohammedsalmaelmukashfieltahir drugshortagecrisisinsudanintimesofcovid19 AT hassankhloodfathi drugshortagecrisisinsudanintimesofcovid19 AT dafallahalaa drugshortagecrisisinsudanintimesofcovid19 AT linxu drugshortagecrisisinsudanintimesofcovid19 AT ahmadiattaullah drugshortagecrisisinsudanintimesofcovid19 AT adeyemisylvester drugshortagecrisisinsudanintimesofcovid19 AT ekpenyonganiekan drugshortagecrisisinsudanintimesofcovid19 AT adebisiyusuffadebayo drugshortagecrisisinsudanintimesofcovid19 |